IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a dengue vaccine protect those with autoimmune conditions?
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a live attenuated dengue vaccine (Butantan-DV) in people aged 12–59 with autoimmune rheumatic diseases like rheumatoid arthritis or lupus, who are stable and on low or no immune-suppressing drugs. Researchers want to see if the vaccine is safe and triggers a…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS)
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:17 UTC
-
Immune cell combo offers new hope for patients with stubborn autoimmune conditions
Disease control Recruiting nowThis study is testing a new treatment for people with certain autoimmune diseases (rheumatoid arthritis, Sjögren's disease, myositis, or scleroderma) that have not responded to standard therapies. The treatment combines a natural killer cell therapy called AlloNK with the drug ri…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS)
Phase: PHASE2 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 11:19 UTC
-
New pill shows promise for rare muscle diseases in early study
Disease control Recruiting nowThis study is testing a daily pill called deucravacitinib in 10 adults with rare muscle inflammation diseases (idiopathic inflammatory myopathies). The goal is to see if the drug improves muscle strength, skin symptoms, and lab results over 6 months. Participants must have active…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS)
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC